×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Egalet's 70% price increase shows the buy-and-hike strategy is alive and well
Fierce Pharma
The drug now carries a list price of $650 per bottle containing 90 pills, Axios reports, citing Elsevier data. Last year, the same bottle cost...
63 months ago
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
PR Newswire
31, 2018 /PRNewswire/ -- Egalet Corporation (OTCQX: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing,...
67 months ago
This arthritis drug cost $198 in 2008. Now it's more than $10000
Axios
In 2008, a box of 30 anti-inflammatory rectal suppositories that treats arthritis, called Indocin, had a price tag of $198. As of Oct. 1,...
31 months ago
Egalet teams up with Valeant division to promote pain-relief nasal spray
Drug Delivery Business
Egalet (NSDQ:EGLT) has partnered with a division of Valeant Pharmaceuticals (NYSE:VRX), OraPharma, to co-promote its pain-relief nasal spray...
77 months ago
FDA panel recommends approval of Egalet abuse-deterrent opioid
Inquirer.com
"That means these morphine medications can be easily abused by chewing, crushing, snorting, or injecting. "We'...
94 months ago
Wayne-based Egalet has stopped manufacturing and promoting Arymo ER pain medicine - Philadelphia Business ...
The Business Journals
Egalet, which is operating under Bankruptcy Court protection, cited 'business reasons' for pulling the plug on its Arymo pain medicine.
66 months ago
Egalet Receives FDA Approval for ARYMO™ ER (morphine sulfate) C-II, an Extended-Release Morphine Product ...
MultiVu
ARYMO ER is the first approved product developed using Egalet's proprietary Guardian™ Technology—a physical and chemical barrier approach to...
88 months ago
FDA approves Egalet's abuse-deterrent morphine Arymo ER
Drug Store News
Egalet said Arymo ER is the first drug approved using its proprietary Guardian Technology, which works to deter abuse and prevent the...
88 months ago
The FDA Missed Egalet's PDUFA Date, But Investors Should Not Be Worried
Yahoo Finance
A miss of the PDUFA date, essentially the "go/no-go date for drug approval" as Russo described it, would normally be bad news for a company. In...
91 months ago
FDA OK with Egalet distributing promotional materials on ARYMO ER's abuse-deterrent properties via intranasal route ...
Seeking Alpha
Egalet (EGLT) is up 13% premarket on light volume in response to its announcement that the FDA will allow it to distribute promotional...
86 months ago